$GRX

The Gabelli Healthcare & WellnessRx Trust: Gabelli Healthcare & WellnessRx Trust Declares Third Quarter Distribution of $0.17 Per Share

The Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) declared a $0.17 per share cash distribution for Q3, payable Sept. 23, 2026 to holders of record Sept. 16, 2026. The fund may also make a December adjusting distribution. It estimates 2026 distributions include 11% net investment income, 47% net capital gains, and 42% return of capital on a book basis.

Original reporting
Published Aug 12, 2026, 2:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 3:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$GRX
Neutral
medium confidence
Mentioned
$GRX
Relevance
4/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$GRXNeutralLow
01

Why it matters

For GRX, the key tradable elements are the declared cash amount and the record/payable dates, plus the estimated tax character mix (net investment income, net capital gains, and return of capital).

02

Market read

This is a distribution-timing and tax-character update rather than a fundamental change, so it is more relevant for income and event-date positioning than for valuation re-rating.

03

What to watch

Final tax character and distribution components can vary after year-end; the article also notes the distribution policy can be modified or terminated by the board.

Relevance 4/10Novelty 4/10Timing: payable Sept. 23, 2026, record date Sept. 16, 2026

Background

Closed-end funds often declare quarterly distributions with potential additional December adjusting distributions to meet RIC minimum distribution requirements.

Company-level read

Ticker impact

$GRXNeutralMedium confidence
Context

Gabelli Healthcare & WellnessRx Trust declared a $0.17 per-share cash distribution payable Sept. 23, 2026 to holders of record Sept. 16.

Expected impact

Likely limited near-term impact; any effect should be small and mostly mechanical around record date and distribution expectations.

Evidence & confidence

The article discloses the declared payout amount and timing, but it does not introduce new portfolio performance, guidance, or a change to distribution policy beyond standard monitoring language.

Market effects

Minor read-through for healthcare and wellness closed-end fund income expectations; no new sector catalyst.

None indicated.

None indicated.

Counterpoint

The stated mix (notably a large estimated return-of-capital share) could signal earnings coverage is not fully supporting distributions, which may matter more than the headline payout.

Key entities

  • The Gabelli Healthcare & WellnessRx Trust

    Declared a $0.17 per-share cash distribution payable Sept. 23, 2026, with record date Sept. 16, 2026.

  • Gabelli Funds, LLC

    Manages the fund; subsidiary of GAMCO Investors, Inc.

Related articles

$GSMed

Goldman Sachs executives set to collect $500M in special bonuses

Goldman Sachs executives, including CEO David Solomon, are set to receive over $500 million in equity awards. The payouts are tied to performance benchmarks, with half contingent on stock price targets and the other half on relative performance against peers. Goldman's stock has met these targets, unlocking the full payout. The awards are part of a 2021 program designed to retain senior executives.

$ORCLMed

Oracle stock falls on more debt to fund AI chip buying, Open AI revenue disclosure

Oracle (ORCL) stock fell after reports it may take on more debt to fund AI chip purchases, with financing talks involving Apollo (APO) and Goldman Sachs (GS). The company's capital spending surged to $28.5B in Q2, up from $2.3B two years prior, while its long-term debt exceeds $160B. OpenAI's (OPAI.PVT) revenue is reportedly $20B below estimates, impacting Oracle's cloud business.

$ORCLHigh

Oracle stock falls on debt deal to fund AI chip buying, Open AI revenue disclosure

Oracle (ORCL) stock dropped after a WSJ report revealed its plans to raise debt for AI chip purchases, with financing talks involving Apollo (APO) and Goldman Sachs (GS). The company's spending surged to $28.5B in Q2, up from $2.3B two years prior, and its debt has nearly doubled to over $160B. OpenAI's (OPAI.PVT) revenue fell short of estimates, impacting Oracle's cloud business.

$LESLMed

Pool supply giant closes 8 stores across the Bay Area

Leslie's, a major U.S. pool supply company, filed for Chapter 11 bankruptcy, closing 76 stores, including 8 in the Bay Area. The company plans to cut 90% of its debt and secure $150M in new capital, aiming to emerge from bankruptcy by early 2027. Leslie's will operate around 900 stores nationwide after closures.

$RIVNMed

Rivian gets $1bn long-term funding from Volkswagen

Rivian Automotive received a $1bn, 10-year loan from Volkswagen Group. The loan, secured by joint venture (JV) assets, has a 5.93% interest rate. Rivian will use the funds for corporate purposes, with repayments starting in 2027. The loan is non-recourse to Rivian, per an SEC filing.

$BIAFMedAI 8/10

WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies (NASDAQ: BIAF) raised $4M via a registered direct offering and private placement, selling shares and warrants at $6.122 each. Proceeds will support working capital and lung cancer test sales. WallachBeth Capital acted as placement agent. Closing expected October 9, 2026.